Fig. 3From: Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable stateLinear discriminant analysis (LDA) effect size (LEfSe) revealed differentially abundant bacterial taxa in stable COPD. The plots from LEfSe analysis indicated differentially enriched bacteria in the LRE vs HRE groups (a), PFT I vs PFT II groups (b), and different medical treatments (c). LRE low-risk exacerbator, HRE high-risk exacerbatorBack to article page